Only about half of health insurer Cigna’s clients currently provide coverage for the high-cost weight loss drugs Wegovy and Zepbound, both of which fall under the GLP-1 class of medications. These drugs have surged in popularity, but their hefty price tags have made many employers hesitant to include them in their insurance plans. In response,…